MDxHealth shareholders approve transition to sole listing shares on Nasdaq

MDxHealth announced that the extraordinary general shareholders’ meeting of the company that was held on November 3 approved the proposed transition from a dual listing of the company’s American Depositary Shares, or ADSs on Nasdaq and ordinary shares on Euronext Brussels to a sole listing of Shares on Nasdaq, as well as the share consolidation with respect to all outstanding shares by means of a 1-for-10 reverse stock split. As a result, the company can now start implementing the transaction and share consolidation, as further outlined below.